Announcements Trials
Browse Landscape

Phase

Phase 1/2 6Phase 1 6Phase 3 3Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Thoracic 1Sarcoma 1Head & Neck 1Genitourinary 1CNS 1

Conditions

Leukemia, Myeloid, Acute 78Lymphoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Leukemia 69Lymphoma, Non-Hodgkin 68Multiple Myeloma 64Leukemia, Lymphocytic, Chronic, B-Cell 63Lymphoma, Large B-Cell, Diffuse 61Myelodysplastic Syndromes 59Lymphoma, Follicular 59Hodgkin Disease 58Lymphoma, Mantle-Cell 52Lymphoma, Large-Cell, Immunoblastic 48Burkitt Lymphoma 47Lymphoma, B-Cell, Marginal Zone 41Leukemia, Myeloid, Chronic-Phase 40Leukemia, Myeloid, Accelerated Phase 40Congenital Abnormalities 39Neoplasms, Plasma Cell 37Myeloproliferative Disorders 37Leukemia, Myelomonocytic, Chronic 31Waldenstrom Macroglobulinemia 29Recurrence 29Blast Crisis 29Primary Myelofibrosis 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Anemia, Refractory, with Excess of Blasts 21Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 20Dendritic Cell Sarcoma, Interdigitating 20Lymphoma, Large-Cell, Anaplastic 19

Interventions

Carboplatin 44Paclitaxel 42Cisplatin 20Topotecan 17Gemcitabine 16Docetaxel 13Bevacizumab 13liposomal doxorubicin 7olaparib 6Cyclophosphamide 6pembrolizumab 5Surgical Procedures, Operative 5Filgrastim 5Etoposide 5Drug Therapy 5Amifostine 5sargramostim 4oregovomab 4catumaxomab 4anlotinib 4Imatinib Mesylate 4Hyperthermic Intraperitoneal Chemotherapy 4rucaparib 3pegfilgrastim 3niraparib 3ixabepilone 3aldesleukin 3Standard of Care 3Peripheral Blood Stem Cell Transplantation 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Ovarian Epithelial × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00003413 2019-10-17

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

University of Maryland, Baltimore

Phase 2 Completed
32 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT00003944 2013-04-17

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Fox Chase Cancer Center

Phase 2 Completed
3 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡